Director/Sr. Director, US Value Assessments, Value Ev. and Outcomes (VEO)
The US Value Evidence and Outcomes organization is leading efforts to increase the US business’s ability to generate, analyze and use real world data and evidence to support the development and commercialization of our medicines.
The US environmental demands for value demonstration continues to increase, with external stakeholders and decision makers increasingly requiring evidence demonstrating comparative clinical, economic, and humanistic benefits of our medicine at the time of launch, and thereafter. There are several external stakeholders incl. regulators, value assessment bodies issuing guidance, frameworks and standards related to the use of these data types, analytical methods, and the overall value assessment of medicines. This is further heightened with the recent passage of the Inflation Reduction Act (IRA) in the US, formalizing the role of value assessment in the later stages of the life cycle.
For GSK and the US business to engage in this space most effectively, the US VEO team is recruiting for a role that will lead a strategic approach to value assessments and IRA response from a value and evidence lens.
*This role and level to be determined, commensurate with experience.
This role will provide YOU the opportunity to lead key activities with high impact to the business that can help progress YOUR career.
These responsibilities include some of the following:
Lead strategy, co-ordination of value evidence inputs to support IRA implementation, this includes, participating in ongoing IRA implementation workstreams, development of value assessment sections (value narrative, supporting evidence for "defining unmet need" and "appropriate treatment comparators") of IRA dossier for CMS negotiation of GSK products.
In partnership with access and policy teams, develop an external engagement strategy with value assessment agencies in the US, i.e.. ICER, IVI, USC Schaffer, etc.
Horizon scan on upcoming ICER appraisals including implications for GSK assets.
Drive strategy and operational management of product specific ICER reviews inclusive of planning activities, engagement of the appropriate VEO and matrix stakeholders, internal & external communications and updates to senior leadership.
Represent GSK on relevant value assessment panels/white papers/ boards, i.e., IVI's Scientific Advisory Panel and at ICERs Methods Advisory, Annual Policy Leadership Summit.
Drive engagement externally around evolving Real World Evidence (RWE) landscape, ensuring proactive involvement in key US healthcare policy efforts, including engagement in relevant PhRMA, BIO, ISPOR, academic, public-private partnerships and advocacy workgroups.
Serve as VEO US point of contact and collaborate proactively with other GSK policy-focused teams (US GAPP, Market Access, Regulatory, Global policy) pertaining to evidence generation and conduit for bidirectional communication between respective teams.
Specifically, participate in Global Corporate Government Affairs & Policy workgroup on HTA landscape monitoring and global strategy development.
Interpret and translate RWE and HTA-related policy changes that impact GSK US and facilitate internal preparedness to effectively respond to changes
Work in conjunction with US Policy and Market Access teams to develop proactive health economics and policy research to demonstrate impact of potential policy reforms in the US .
We are looking for professionals with these required skills to achieve our goals:
MS or PhD in a healthcare concentration, PharmD or MBA.
Demonstrated experience of Health Economics, Outcomes Research, Epidemiology, Medical Affairs, the science of the pharmaceutical industry, and the US policy landscape.
3+ years direct experience in value-related policy activities.
3+ years’ experience within the pharmaceutical industry.
Experience in reimbursement and access, health economics and/or outcomes research.
If you have the following characteristics, it would be a plus:
Deep understanding of US reimbursement systems, healthcare market and decision-makers.
Experienced in interacting with all levels of management and staff.
Business knowledge and application to problem solving.
Excellent verbal, written, presentation and organizational skills.
Comfortable enabling and driving change.
Ability to engaging and develop others.
Influence in cross-functional matrix.
Our values and expectations are at the heart of everything we do and form an important part of our culture.
These include Patient focus, Transparency, Respect, Integrity along with Courage, Accountability, Development, and Teamwork. As GSK focuses on our values and expectations and a culture of innovation, performance, and trust, the successful candidate will demonstrate the following capabilities:
Agile and distributed decision-making – using evidence and applying judgement to balance pace, rigour and risk.
Managing individual and team performance.
Committed to delivering high quality results, overcoming challenges, focusing on what matters, execution.
Implementing change initiatives and leading change.
Sustaining energy and well-being, building resilience in teams.
Continuously looking for opportunities to learn, build skills and share learning both internally and externally.
Developing people and building a talent pipeline.
Translating strategy into action - a compelling narrative, motivating others, setting objectives and delegation.
Building strong relationships and collaboration, managing trusted stakeholder relationships internally and externally.
Budgeting and forecasting, commercial and financial acumen.
GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to positively impact the health of 2.5 billion people by the end of 2030.
Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a workplace where everyone can feel a sense of belonging and thrive as set out in our Equal and Inclusive Treatment of Employees policy. We’re committed to being more proactive at all levels so that our workforce reflects the communities we work and hire in, and our GSK leadership reflects our GSK workforce.
GSK is an Equal Opportunity Employer and, in the US, we adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.
Important notice to Employment businesses/ Agencies
GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.
Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit GSK’s Transparency Reporting [Register to View] site.